{"prompt": "['Date and Version No: 7 19/12/19', '5.', 'OBJECTIVES', 'CONFIDENTIAL', 'Page 18 of 57', 'The Cognition and Flow Study']['Date and Version No: 7 19/12/19', '5.1', 'Primary Objectives', 'The primary objective of this study is to determine the ability to carry out (feasibility) a large', 'scale RCT of CT in healthy older adults, and people with AzD and MCI.', '5.2 Secondary Objectives', '1) Are there any clinical benefits of a brain training program in patients with dementia and', 'any difference between groups (MCI/AzD/healthy older adults/post-ischaemic stroke) in', 'ability to carry out everyday activities, memory, mood, and quality of life outcomes?', '2) Are there any changes in blood flow responses to cognitive tasks using TCD before and', 'after brain training?', '3) Are there any brain blood flow markers that can be used to predict who will benefit from', 'brain training, and in which memory areas to generate a personalised training plan for', 'individual patients?', '5.3 Qualitative Study Objectives', '1) What are the barriers to brain training in patients with dementia?', '2) What are the facilitators (benefits) to brain training in patients with dementia?', '3) Could brain training programs be adapted further to support the participation of patients', 'with dementia?', '4) Are there any additional benefits to brain training programs not measured by traditional', 'methods as perceived by the patients and their carers?', '5) To explore the lived experience of the patient and their carer and the impact brain training', 'has on them and their life.', 'CONFIDENTIAL', 'Page 19 of 57', 'The Cognition and Flow Study']['Date and Version No: 7 19/12/19', '6.', 'STUDY DESIGN', '6.1', 'Summary of Trial Design', 'This is a prospective, feasibility, RCT of CT in healthy older adults, and adults with', 'AzD, MCI, or post-ischaemic stroke. This trial is un-blinded, due to the nature of the', 'intervention. The expected duration of participation per individual is three to six', 'months. Initially, participants will be approached by a member of the clinical care team', 'or research support staff, who will screen and identify eligible participants. Study', 'specific information will then be provided by the researcher. Following this,', 'participants will undergo informed consent. Each participant will have two visits (initial', 'and follow-up assessment). After the first visit, participants will be randomised to', 'control or intervention (CT), and will complete an 8-12 week CT program, if selected', 'for the intervention group. Participants will be randomised using Sealed Envelope C,', 'an online, commercially available randomisation tool. At the end of the trial,', 'participants will be given the option to participate in a qualitative study by semi-', 'structured interviews or focus group. A flow chart for this process can be seen in', 'Appendix A.', 'CONFIDENTIAL', 'Page 20 of 57', 'The Cognition and Flow Study']\n\n###\n\n", "completion": "END"}